drugset / Trial / NCT00638053
A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the prevalence of GHD in patients who sustain a head injury or suffer a major traumatic event and to evaluate the efficacy of growth hormone (GH) therapy in the treatment of GHD caused by trauma or head injury
Timeline
- Start
- 2002-11
- Primary completion
- —
- Completion
- 2003-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somatropin | Protein / enzyme biologic | 0.1 mg | Subcutaneous |
| Subject | Somatropin | Protein / enzyme biologic | 0.2 mg | Subcutaneous |